Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.24.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Nov. 30, 2022 24,018,612   (2,165,987)      
Balance at Nov. 30, 2022 $ 23 $ 125,474 $ (17,500) $ (61,383) $ (620) $ 45,994
Stock-based compensation $ 0 1,464 $ 0 0 0 1,464
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 13,636   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 0 $ 0 0 0 0
Net income (loss) for the period 0 0 0 (2,153) 0 (2,153)
Foreign currency translation adjustment for the period 0 0 0 0 (585) (585)
Net loss $ 0 0 $ 0 (2,153) 0 (2,153)
Balance (in shares) at Feb. 28, 2023 24,032,248   (2,165,987)      
Balance at Feb. 28, 2023 $ 23 126,938 $ (17,500) (63,536) (1,205) 44,720
Balance (in shares) at Nov. 30, 2023 24,168,014   (2,165,987)      
Balance at Nov. 30, 2023 $ 24 130,426 $ (17,500) (69,575) (1,056) 42,319
Stock-based compensation $ 0 938 $ 0 0 0 $ 938
Issuance of common stock pursuant to exercise of stock options (in shares) 167,967   0     205,000
Issuance of common stock pursuant to exercise of stock options $ 0 10 $ 0 0 0 $ 10
Issuance of common stock pursuant to vesting of restricted stock units (in shares) 39,773   0      
Issuance of common stock pursuant to vesting of restricted stock units $ 0 0 $ 0 0 0 0
Net income (loss) for the period 0 0 0 17 0 17
Foreign currency translation adjustment for the period 0 0 0 0 (115) (115)
Net loss $ 0 0 $ 0 17 0 17
Balance (in shares) at Feb. 29, 2024 24,375,754   (2,165,987)      
Balance at Feb. 29, 2024 $ 24 $ 131,374 $ (17,500) $ (69,558) $ (1,171) $ 43,169